matriptase inhibitors (NCI/Georgetown University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namematriptase inhibitors (NCI/Georgetown University)
Drug Alias NameSFTI-1 analogs (NCI/Georgetown)serine protease inhibitors (NCI/Georgetown)SFTI-11
ClassificationBiologics
Mechanisms of ActionSuppressor of tumorigenicity 14 protein inhibitorsTrypsin inhibitors
TargetsTrypsinSuppressor of tumorigenicity 14 protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeorgetown University Medical CenterNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A